Literature DB >> 21126641

Antiplatelet therapy and coronary artery bypass graft surgery a fallow land.

Gilles Montalescot, Jean-Sébastien Hulot, Jean-Philippe Collet.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 21126641     DOI: 10.1016/j.jacc.2010.05.060

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis.

Authors:  Peter K Smith; Lawrence T Goodnough; Jerrold H Levy; Robert S Poston; Mary A Short; Govinda J Weerakkody; Leroy A Lenarz
Journal:  J Am Coll Cardiol       Date:  2012-05-23       Impact factor: 24.094

Review 2.  Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials.

Authors:  Subodh Verma; Shaun G Goodman; Shamir R Mehta; David A Latter; Marc Ruel; Milan Gupta; Bobby Yanagawa; Mohammed Al-Omran; Nandini Gupta; Hwee Teoh; Jan O Friedrich
Journal:  BMC Surg       Date:  2015-10-14       Impact factor: 2.102

3.  The influence of hypothermia on transfusion requirement in patients who received clopidogrel in proximity to off-pump coronary bypass surgery.

Authors:  Bo Ra Lee; Jong Wook Song; Young Lan Kwak; Kyoung Jong Yoo; Jae Kwang Shim
Journal:  Yonsei Med J       Date:  2014-01       Impact factor: 2.759

4.  Effects of ulinastatin on coagulation in high-risk patients undergoing off-pump coronary artery bypass graft surgery.

Authors:  Na-Young Kim; Jae-Kwang Shim; Seo-Ouk Bang; Jee-Suk Sim; Jong-Wook Song; Young-Lan Kwak
Journal:  Korean J Anesthesiol       Date:  2013-02-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.